Intravenous Solution Market

ID: 727

124 Pages

Research Team

06/2021

Intravenous solution market Research Report Information By Nutrition Type (Peripheral Parenteral Nutrition and Total Parenteral Nutrition), By Bag Type (Large Volume Bags (>250 ml) and Small Volume Bags (<250 ml)), By Nutritional Content (Amino Acid Solution, Carbohydrates, Vitamins & Minerals, Parenteral Lipid Emulsion, and Others), By End User (Hospital & Clinics, Ambulatory Sur...

Single User

$ 4,950.0

Multiple License

$ 5,950.0

Enterprise User

$ 7,250.0

1. Market Overview

2. Market Trends

3. Market Segment Insights

4. Key Players and Competitive Insights

5. Industry Developments

6. Market Segmentation

7. Report Scope

8. Market Highlights

9. FAQs

Certified Researchers

Market Summary

Research Methodology on Intravenous Solution Market

1. Objective of the Study:

The main objective of this study is to understand the current market trends, drivers, and dynamics of the Intravenous (IV) Solution market and assess the potential of the Intravenous Solution market to enable the stakeholders in understanding the investment opportunities in the market.

2. Definition of Intravenous Solution:

An intravenous solution is a solution prepared to be delivered directly into the bloodstream via a vein. These solutions can be normal saline or other solutions containing glucose, electrolytes, and vitamins, and are used to replace lost body fluids or provide nutrients to the patient.

3. Research Philosophy:

The research philosophy adopted for this study is positivism. This philosophy is based on the notion that the truth can be established through the observation and analysis of the cause-effect relation of the particular phenomena under study.

4. Research Approach:

The study includes primary and secondary data collection and analysis. The secondary data sources used include press releases, the company’s official reports, world literature, and white papers. The secondary research involves gathering data from existing databases, reports, and other published literature. The primary research is conducted to validate the information gathered through secondary research and analyze the present market scenario.

The primary research interviews are conducted to obtain the insights of the market experts. Qualitative and quantitative research methodologies are adopted to understand and define the present market trends and get detailed information on the Intravenous solution market characteristics.

The qualitative methodologies used include focus group discussions, in-depth interviews, and feedback sessions. A brief description of the qualitative methodologies used is given below:

Focus Group Discussions:

This method is conducted to understand the market dynamics and to get insights into the Intravenous Solution market. The participants for this method consisted of industry experts and key opinion leaders (KOLs).

In-depth Interviews:

These interviews are conducted with the top management staff of the vendors operating in the Intravenous Solution market. The objective is to understand their opinion and insights about the Intravenous Solution market.

Feedback Sessions:

These sessions were conducted to get the opinion of industry experts and key opinion leaders about different aspects of the Intravenous Solution market.

The quantitative methodologies used in the study include market sizing, forecasting, regression analysis, and Monte Carlo simulation. A brief description of the quantitative methodologies used is given below:

Market Sizing:

The top-down and bottom-up approaches were used to size the global Intravenous Solution market. The market size is estimated by dividing the total addressable market into different segments and geographies.

Forecasting:

The forecasting technique is used to predict future trends in the Intravenous Solution market. The forecasting method is based on historical data, current market trends, and inputs from industry experts.

Regression Analysis:

The regression analysis is used to analyze the trends in the Intravenous Solution market. This is used to identify the cause-and-effect relationship of different factors influencing the market.

Monte Carlo Simulation:

The Monte Carlo simulation is used to evaluate the impact of different parameters on the Intravenous Solution market. This was used to identify the most likely outcome of the global Intravenous Solution market.

5. Data Collection Tools:

The data collection tools used for this study include primary and secondary research. The primary research involved conducting interviews with industry experts, key opinion leaders (KOLs), and other stakeholders. The contact details of the third-party data sources used to validate the data collected through primary and secondary research methodologies are mentioned in the Bibliography section of the report.

6. Sampling Techniques:

The sampling technique used in this study is two-stage sampling. In the first stage, the population sample was segmented into sub-samples based on geographies and end-user industries. This sample was then randomly selected for data collection in the second stage.

7. Variables:

The following are the variables used in the study:

Drivers: Government regulations, medical advances, and market consolidation.

Restraints: Shortage of healthcare professionals and high cost of machinery.

Opportunities: Increased demand for IV solutions, the introduction of new products and services, and growth in the geriatric population.

Challenges: Lack of awareness, regulatory constraints, and deficiencies in healthcare infrastructure.

8. Model Assumptions:

The assumptions used in the study are based on the insights gained from the primary research interviews with industry experts and KOLs.

9. Data Triangulation:

The dataset for this study is gathered from both primary and secondary sources. The data is triangulated to verify the reliability of the data gathered from each source and ensure that the data is factual and reliable.

10. Research Data Validation:

The research data is validated with the help of experts and KOLs in the Intravenous Solution market. The validation is done through primary research interviews. After collecting the primary data, a detailed analysis of the data is done to identify the accuracy of the data.

Market Size & Forecast

Attribute/Metric	Details
Market Size 2023	USD 13.9 billion
Market Size 2024	USD 14.97 billion
Market Size 2032	USD 26.59 billion
Compound Annual Growth Rate (CAGR)	7.7% (2024-2032)
Base Year	2023
Market Forecast Period	2024-2032
Historical Data	2018 & 2022
Market Forecast Units	Value (USD Billion)
Report Coverage	Market Competitive Landscape, Revenue Forecast, Growth Factors, and Trends
Segments Covered	Nutrition Type, Bag Type, Nutritional Content, End User, and Region
Geographies Covered	Europe, North America, Asia Pacific, and the Rest of the World
Countries Covered	The U.S, Germany, Canada, the UK, France, Italy, Spain, India, Japan, Australia, China, South Korea, and Brazil
Key Companies Profiled	Baxter International Inc (US), Fresenius SE & Co. KGaA (Germany), Braun Melsungen AG (Germany), ICU Medical Inc (US), Pfizer Inc (US), Grifols S.A. (Spain), Terumo Medical Corporation (Japan)
Key Market Opportunities	A Rise in demand for intravenous solutions from developing countries Emerging launches of parenteral (intravenous) nutrition (PN) products
Key Market Dynamics	Growing regulatory approvals for intravenous solution injections Increased intravenous vitamin C administration for colorectal cancer patients

Major Players

Market Segmentation Tab

Intravenous Solution Nutrition Type Outlook (USD Million, 2018-2030)

Total Parenteral Nutrition
Peripheral Parenteral Nutrition

Intravenous Solution Bag Type Outlook (USD Million, 2018-2030)

Large Volume Bags (>250 ml)
Small Volume Bags (<250 ml)

Intravenous Solution Nutritional Content Outlook (USD Million, 2018-2030)

Amino Acid Solution
Carbohydrates
Vitamins & Minerals
Parenteral Lipid Emulsion

Intravenous Solution End User Outlook (USD Million, 2018-2030)

Hospital & Clinics
Ambulatory Surgical Centers
Home Care

Intravenous Solution Regional Outlook (USD Million, 2018-2030)

North America Outlook (USD Million, 2018-2030)
- North America Intravenous Solution by Nutrition Type
  - Total Parenteral Nutrition
  - Peripheral Parenteral Nutrition
- North America Intravenous Solution by Bag Type
  - Large Volume Bags (>250 ml)
  - Small Volume Bags (<250 ml)
- North America Intravenous Solution by Nutritional Content
  - Amino Acid Solution
  - Carbohydrates
  - Vitamins & Minerals
  - Parenteral Lipid Emulsion
- North America Intravenous Solution by End User
  - Hospital & Clinics
  - Ambulatory Surgical Centers
  - Home Care
- US Outlook (USD Million, 2018-2030)
- US Intravenous Solution by Nutrition Type
  - Total Parenteral Nutrition
  - Peripheral Parenteral Nutrition
- US Intravenous Solution by Bag Type
  - Large Volume Bags (>250 ml)
  - Small Volume Bags (<250 ml)
- US Intravenous Solution by Nutritional Content
  - Amino Acid Solution
  - Carbohydrates
  - Vitamins & Minerals
  - Parenteral Lipid Emulsion
- US Intravenous Solution by End User
  - Hospital & Clinics
  - Ambulatory Surgical Centers
  - Home Care
- CANADA Outlook (USD Million, 2018-2030)
- CANADA Intravenous Solution by Nutrition Type
  - Total Parenteral Nutrition
  - Peripheral Parenteral Nutrition
- CANADA Intravenous Solution by Bag Type
  - Large Volume Bags (>250 ml)
  - Small Volume Bags (<250 ml)
- CANADA Intravenous Solution by Nutritional Content
  - Amino Acid Solution
  - Carbohydrates
  - Vitamins & Minerals
  - Parenteral Lipid Emulsion
- CANADA Intravenous Solution by End User
  - Hospital & Clinics
  - Ambulatory Surgical Centers
  - Home Care
- Europe Outlook (USD Million, 2018-2030)
  - Europe Intravenous Solution by Nutrition Type
    - Total Parenteral Nutrition
    - Peripheral Parenteral Nutrition
  - Europe Intravenous Solution by Bag Type
    - Large Volume Bags (>250 ml)
    - Small Volume Bags (<250 ml)
  - Europe Intravenous Solution by Nutritional Content
    - Amino Acid Solution
    - Carbohydrates
    - Vitamins & Minerals
    - Parenteral Lipid Emulsion
  - Europe Intravenous Solution by End User
    - Hospital & Clinics
    - Ambulatory Surgical Centers
    - Home Care
  - Germany Outlook (USD Million, 2018-2030)
  - Germany Intravenous Solution by Nutrition Type
    - Total Parenteral Nutrition
    - Peripheral Parenteral Nutrition
  - Germany Intravenous Solution by Bag Type
    - Large Volume Bags (>250 ml)
    - Small Volume Bags (<250 ml)
  - Germany Intravenous Solution by Nutritional Content
    - Amino Acid Solution
    - Carbohydrates
    - Vitamins & Minerals
    - Parenteral Lipid Emulsion
  - Germany Intravenous Solution by End User
    - Hospital & Clinics
    - Ambulatory Surgical Centers
    - Home Care
  - France Outlook (USD Million, 2018-2030)
  - France Intravenous Solution by Nutrition Type
    - Total Parenteral Nutrition
    - Peripheral Parenteral Nutrition
  - France Intravenous Solution by Bag Type
    - Large Volume Bags (>250 ml)
    - Small Volume Bags (<250 ml)
  - France Intravenous Solution by Nutritional Content
    - Amino Acid Solution
    - Carbohydrates
    - Vitamins & Minerals
    - Parenteral Lipid Emulsion
  - France Intravenous Solution by End User
    - Hospital & Clinics
    - Ambulatory Surgical Centers
    - Home Care
  - UK Outlook (USD Million, 2018-2030)
  - UK Intravenous Solution by Nutrition Type
    - Total Parenteral Nutrition
    - Peripheral Parenteral Nutrition
  - UK Intravenous Solution by Bag Type
    - Large Volume Bags (>250 ml)
    - Small Volume Bags (<250 ml)
  - UK Intravenous Solution by Nutritional Content
    - Amino Acid Solution
    - Carbohydrates
    - Vitamins & Minerals
    - Parenteral Lipid Emulsion
  - UK Intravenous Solution by End User
    - Hospital & Clinics
    - Ambulatory Surgical Centers
    - Home Care
  - ITALY Outlook (USD Million, 2018-2030)
  - ITALY Intravenous Solution by Nutrition Type
    - Total Parenteral Nutrition
    - Peripheral Parenteral Nutrition
  - ITALY Intravenous Solution by Bag Type
    - Large Volume Bags (>250 ml)
    - Small Volume Bags (<250 ml)
  - ITALY Intravenous Solution by Nutritional Content
    - Amino Acid Solution
    - Carbohydrates
    - Vitamins & Minerals
    - Parenteral Lipid Emulsion
  - ITALY Intravenous Solution by End User
    - Hospital & Clinics
    - Ambulatory Surgical Centers
    - Home Care
  - SPAIN Outlook (USD Million, 2018-2030)
  - Spain Intravenous Solution by Nutrition Type
    - Total Parenteral Nutrition
    - Peripheral Parenteral Nutrition
  - Spain Intravenous Solution by Bag Type
    - Large Volume Bags (>250 ml)
    - Small Volume Bags (<250 ml)
  - Spain Intravenous Solution by Nutritional Content
    - Amino Acid Solution
    - Carbohydrates
    - Vitamins & Minerals
    - Parenteral Lipid Emulsion
  - Spain Intravenous Solution by End User
    - Hospital & Clinics
    - Ambulatory Surgical Centers
    - Home Care
  - Rest Of Europe Outlook (USD Million, 2018-2030)
  - Rest Of Europe Intravenous Solution by Nutrition Type
    - Total Parenteral Nutrition
    - Peripheral Parenteral Nutrition
  - REST OF EUROPE Intravenous Solution by Bag Type
    - Large Volume Bags (>250 ml)
    - Small Volume Bags (<250 ml)
  - REST OF EUROPE Intravenous Solution by Nutritional Content
    - Amino Acid Solution
    - Carbohydrates
    - Vitamins & Minerals
    - Parenteral Lipid Emulsion
  - REST OF EUROPE Intravenous Solution by End User
    - Hospital & Clinics
    - Ambulatory Surgical Centers
    - Home Care
  - Asia-Pacific Outlook (USD Million, 2018-2030)
    - Asia-Pacific Intravenous Solution by Nutrition Type
      - Total Parenteral Nutrition
      - Peripheral Parenteral Nutrition
    - Asia-Pacific Intravenous Solution by Bag Type
      - Large Volume Bags (>250 ml)
      - Small Volume Bags (<250 ml)
    - Asia-Pacific Intravenous Solution by Nutritional Content
      - Amino Acid Solution
      - Carbohydrates
      - Vitamins & Minerals
      - Parenteral Lipid Emulsion
    - Asia-Pacific Intravenous Solution by End User
      - Hospital & Clinics
      - Ambulatory Surgical Centers
      - Home Care
    - China Outlook (USD Million, 2018-2030)
    - China Intravenous Solution by Nutrition Type
      - Total Parenteral Nutrition
      - Peripheral Parenteral Nutrition
    - China Intravenous Solution by Bag Type
      - Large Volume Bags (>250 ml)
      - Small Volume Bags (<250 ml)
    - China Intravenous Solution by Nutritional Content
      - Amino Acid Solution
      - Carbohydrates
      - Vitamins & Minerals
      - Parenteral Lipid Emulsion
    - China Intravenous Solution by End User
      - Hospital & Clinics
      - Ambulatory Surgical Centers
      - Home Care
    - Japan Outlook (USD Million, 2018-2030)
    - Japan Intravenous Solution by Nutrition Type
      - Total Parenteral Nutrition
      - Peripheral Parenteral Nutrition
    - Japan Intravenous Solution by Bag Type
      - Large Volume Bags (>250 ml)
      - Small Volume Bags (<250 ml)
    - Japan Intravenous Solution by Nutritional Content
      - Amino Acid Solution
      - Carbohydrates
      - Vitamins & Minerals
      - Parenteral Lipid Emulsion
    - Japan Intravenous Solution by End User
      - Hospital & Clinics
      - Ambulatory Surgical Centers
      - Home Care
    - India Outlook (USD Million, 2018-2030)
    - India Intravenous Solution by Nutrition Type
      - Total Parenteral Nutrition
      - Peripheral Parenteral Nutrition
    - India Intravenous Solution by Bag Type
      - Large Volume Bags (>250 ml)
      - Small Volume Bags (<250 ml)
    - India Intravenous Solution by Nutritional Content
      - Amino Acid Solution
      - Carbohydrates
      - Vitamins & Minerals
      - Parenteral Lipid Emulsion
    - India Intravenous Solution by End User
      - Hospital & Clinics
      - Ambulatory Surgical Centers
      - Home Care
    - Australia Outlook (USD Million, 2018-2030)
    - Australia Intravenous Solution by Nutrition Type
      - Total Parenteral Nutrition
      - Peripheral Parenteral Nutrition
    - Australia Intravenous Solution by Bag Type
      - Large Volume Bags (>250 ml)
      - Small Volume Bags (<250 ml)
    - Australia Intravenous Solution by Nutritional Content
      - Amino Acid Solution
      - Carbohydrates
      - Vitamins & Minerals
      - Parenteral Lipid Emulsion
    - Australia Intravenous Solution by End User
      - Hospital & Clinics
      - Ambulatory Surgical Centers
      - Home Care
    - Rest of Asia-Pacific Outlook (USD Million, 2018-2030)
    - Rest of Asia-Pacific Intravenous Solution by Nutrition Type
      - Total Parenteral Nutrition
      - Peripheral Parenteral Nutrition
    - Rest of Asia-Pacific Intravenous Solution by Bag Type
      - Large Volume Bags (>250 ml)
      - Small Volume Bags (<250 ml)
    - Rest of Asia-Pacific Intravenous Solution by Nutritional Content
      - Amino Acid Solution
      - Carbohydrates
      - Vitamins & Minerals
      - Parenteral Lipid Emulsion
    - Rest of Asia-Pacific Intravenous Solution by End User
      - Hospital & Clinics
      - Ambulatory Surgical Centers
      - Home Care
    - Rest of the World Outlook (USD Million, 2018-2030)
      - Rest of the World Intravenous Solution by Nutrition Type
        Total Parenteral Nutrition
        Peripheral Parenteral Nutrition
      - Rest of the World Intravenous Solution by Bag Type
        Large Volume Bags (>250 ml)
        Small Volume Bags (<250 ml)
      - Rest of the World Intravenous Solution by Nutritional Content
        Amino Acid Solution
        Carbohydrates
        Vitamins & Minerals
        Parenteral Lipid Emulsion
      - Rest of the World Intravenous Solution by End User
        Hospital & Clinics
        Ambulatory Surgical Centers
        Home Care
      - Middle East Outlook (USD Million, 2018-2030)
      - Middle East Intravenous Solution by Nutrition Type
        Total Parenteral Nutrition
        Peripheral Parenteral Nutrition
      - Middle East Intravenous Solution by Bag Type
        Large Volume Bags (>250 ml)
        Small Volume Bags (<250 ml)
      - Middle East Intravenous Solution by Nutritional Content
        Amino Acid Solution
        Carbohydrates
        Vitamins & Minerals
        Parenteral Lipid Emulsion
      - Middle East Intravenous Solution by End User
        Hospital & Clinics
        Ambulatory Surgical Centers
        Home Care
      - Africa Outlook (USD Million, 2018-2030)
      - Africa Intravenous Solution by Nutrition Type
        Total Parenteral Nutrition
        Peripheral Parenteral Nutrition
      - Africa Intravenous Solution by Bag Type
        Large Volume Bags (>250 ml)
        Small Volume Bags (<250 ml)
      - Africa Intravenous Solution by Nutritional Content
        Amino Acid Solution
        Carbohydrates
        Vitamins & Minerals
        Parenteral Lipid Emulsion
      - Africa Intravenous Solution by End User
        Hospital & Clinics
        Ambulatory Surgical Centers
        Home Care
      - Latin America Outlook (USD Million, 2018-2030)
      - Latin America Intravenous Solution by Nutrition Type
        Total Parenteral Nutrition
        Peripheral Parenteral Nutrition
      - Latin America Intravenous Solution by Bag Type
        Large Volume Bags (>250 ml)
        Small Volume Bags (<250 ml)
      - Latin America Intravenous Solution by Nutritional Content
        Amino Acid Solution
        Carbohydrates
        Vitamins & Minerals
        Parenteral Lipid Emulsion
      - Latin America Intravenous Solution by End User
        Hospital & Clinics
        Ambulatory Surgical Centers
        Home Care

Market Trends

Global Intravenous Solution Market Overview

The Intravenous Solution Market Valued at USD 13.9 billion in 2023, projected to grow from USD 15.0 billion in 2024 to USD 26.60 billion by 2032, exhibiting a CAGR of 7.70% during the forecast period (2024 - 2032). The key factors driving the expansion of the intravenous solution market include rising chronic disease incidence and prevalence, an aging global population, and rapidly increasing healthcare spending on IV therapy treatment.

Intravenous Solution Market Overview

Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review

Intravenous Solution Market Trends

Growing launches and regulatory approvals for intravenous solution injection to drive growth

New intravenous injection solutions are being introduced by market participants, which is anticipated to accelerate the growth of the global intravenous solutions market in the upcoming years. For example, Baxter International Inc., a global sterile medication production company, announced the FDA approval and commercial launch of premix Bitartrate in 5% Dextrose Injection in September 2021. In adults with severe, acute hypotension, is prescribed to raise blood pressure (low blood pressure). Baxter's formu...

Market Segment Insights

Smartphone Sensors Smartphone Type Insights

The Smartphone Sensors market segmentation, based on smartphone type, includes standard smartphone, rugged smartphone, smartwatches, and other wearable. The standard smartphone segment dominated the market, accounting for the maximum market revenue. A smartphone is a mobile phone with a built-in computer and advanced features, such as web browsing and operating system, which are not associated with its counterpart. The rising mobile internet use, rising disposable income in developing countries, and high ownership of premium design smartphones are a few factors that are anticipated to grow smartphone sales. Smartphones are helped by a mobile operating system that offers advanced computing facilities. A smartphone can also work as a digital media player for uploading photos, videos, and music through a single interface.

Smartphone Sensors Market, By Device Type Outlook, 2024 & 2035

Smartphone Sensors Manufacturer Insights

The Smartphone Sensors market segmentation, based on the manufacturer, includes Apple Inc., Samsung Electronics, Huawei Technology, Xiaomi Inc., Oppo, Sony Corporation, HMD Global, and others. The Apple Inc. segment generated the most revenue due to its superior quality. Apple’s iPhone stands out over all other smartphones in the market. Apple Inc. is the market leader because they use more sensors in their devices to provide unique features. For Instance: Apple’s iPhone 12 uses a lidar for depth sensing, proximity for 3D touch, a gyroscope for compass, GPS, face ID for biometrics, auto-off, a barometer, a magnetometer for compass & GPS, and an ambient light sensor for auto-dimming displays. The better user experience, increased accessibility, and more security these sensors offer consumers to boost the segment‘s growth.

Smartphone Sensors Application Insights

Smartphone Sensors Regional Insights

Smartphone Sensors Market, By Device Type Outlook, 2024 & 2035

Smartphone Sensors Price Insights

The Smartphone Sensors market segmentation, based on price, includes USD 300 to USD 500, USD 100 to USD 300, above USD 500, and under USD 100. The USD 300 to USD 500 segment dominated the market revenue in the projected period. Most smartphones sold in medium-end devices have a sensor within this range. For instance: Nubia launched a new flagship Android device powered by the latest Snapdragon 8Gen 2CPU. The OEM has also specified that this gadget, which peculiarly seems to go by the name Z50 even though its processor was the z40 Pro, will compete with the Xiaomi 13 and iQOO11 series with cutting-edge LPDDR5X RAM and storage with the most recent UFS 4.0 spec.

Get more detailed insights about Intravenous Solution Market

Key Players and Competitive Insights

Leading market players are investing heavily in research and development to expand their product lines, which will help the Smartphone Sensors market, grow even more. Market participants are also undertaking various strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and growing market climate, the Smartphone Sensors industry must offer cost-effective items.

Manufacturing locally to minimize operational costs is one of the key business tactics manufacturers use in the Smartphone Sensors industry to benefit clients and increase the market sector. In recent years, the Smartphone Sensors industry has offered manufacturers some of the most significant advantages. Major players in the Smartphone Sensors market, including MS AG (Austria), Broadcom Inc. (US), DYNA IMAGE Corporation (China), Murata Electronics Oy (Finland), NEXT Biometrics Group ASA (Norway), Omron Corporation (Japan), Samsung Electronics Co. Ltd. (South Korea), Sony Corporation (Japan)., and others, are attempting to increase market demand by investing in research and development operations.

Samsung is dedicated to abiding by local laws and regulations and enforcing a strict code of conduct for all employees. Samsung adheres to a straightforward business tent: to usage its technology and expertise to develop top-notch goods and services that make a more cultured world. Samsung provides a high importance on its people and technologies to do this. For Instance: In January 2023, Samsung Electronics launched its new MICRO LED, Neo QLED, and Samsung OLED product lines, along with lifestyle products and accessories, before CES® 2023.

Apple Inc. is a multinational American technology business with its main office in Cupertino, California. According to revenue, Apple will be the top technological business in the world in 2022, with US $ 394.3 billion in sales. According to market capitalization, Apple is the largest corporation in the world as of March 2023. For Instance: In September 2022, the iPhone 14 and iPhone 14 Plus, which come in two sizes, 6.1 and 6.7 inches and include a smart design, camera upgrades, and game-changing new safety measures, were introduced by Apple. The iPhone 14 and iPhone 14 Plus have a powerful camera system that incorporates the primary and front TrueDepth cameras, the Ultra Wide camera for uncommon perspectives, and the photonic engine, an enhanced picture pipeline.

Key Companies in the Smartphone Sensors market include

MS AG (Austria)

Industry Developments

September 2022: Comcast and Samsung Electronics announced their partnership to create 5G Radio Access Network (RAN) technologies to enhance 5G connection for Xfinity Mobile and Comcast Business Mobile users in Comcast service zones. Samsung will provide 5G RAN technology, and Comcast will deploy Citizens Broadband Radio Service (CBRS) and 600 MHz spectrum to provide 5G access to consumer and business users in the US.
October 2022: Huawei announced the release of the newest antenna solutions, including the Maxwell platform and the X2 antenna series, for the subsequent 5G antenna innovation stage. The new technologies speed up 5G deployment by improving antenna and setup capabilities.

Market Segmentation

Smartphone Type Outlook

Standard Smartphone
Rugged Smartphone
Smartwatches
Other Wearable

Price Outlook

USD 300 to USD 500
USD 100 to USD 300
Above USD 500
Under USD 100

Manufacturer Outlook

Apple Inc.
Samsung Electronics
Huawei Technology
Xiaomi Inc.

Oppo
Sony Corporation
HMD Global

Application Outlook

High-Level
Mid-Level
Low-Level

Manufacturer Outlook

North America

US
Canada

Europe

Germany
France
UK
Italy
Spain
Rest of Europe

Asia-Pacific

China
Japan
India
Italy
Australia
South Korea
Rest of Asia-Pacific

Rest of the World

Middle East
Africa
Latin America

Report Scope

Attribute/Metric	Details
Market Size 2023	USD 13.9 billion
Market Size 2024	USD 14.97 billion
Market Size 2032	USD 26.59 billion
Compound Annual Growth Rate (CAGR)	7.7% (2024-2032)
Base Year	2023
Market Forecast Period	2024-2032
Historical Data	2018 & 2022
Market Forecast Units	Value (USD Billion)
Report Coverage	Market Competitive Landscape, Revenue Forecast, Growth Factors, and Trends
Segments Covered	Nutrition Type, Bag Type, Nutritional Content, End User, and Region
Geographies Covered	Europe, North America, Asia Pacific, and the Rest of the World
Countries Covered	The U.S, Germany, Canada, the UK, France, Italy, Spain, India, Japan, Australia, China, South Korea, and Brazil
Key Companies Profiled	Baxter International Inc (US), Fresenius SE & Co. KGaA (Germany), Braun Melsungen AG (Germany), ICU Medical Inc (US), Pfizer Inc (US), Grifols S.A. (Spain), Terumo Medical Corporation (Japan)
Key Market Opportunities	A Rise in demand for intravenous solutions from developing countries Emerging launches of parenteral (intravenous) nutrition (PN) products
Key Market Dynamics	Growing regulatory approvals for intravenous solution injections Increased intravenous vitamin C administration for colorectal cancer patients

Market Highlights

Author

Aarti Dhapte

Team Lead - Research

She holds an experience of about 6+ years in market research and business consulting, working under the spectrum of information communication technology, telecommunications and semiconductor domains. aarti conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. her expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.

Latest Comments

John Doe

john@example.com

This is a great article! Really helped me understand the topic better.

Posted on July 23, 2025, 10:15 AM

Jane Smith

jane@domain.com

Thanks for sharing this. I’ve bookmarked it for later reference.

Posted on July 22, 2025, 7:45 PM

View All

FAQs

At what CAGR is the Intravenous Solution Market projected to grow during the forecast period?

Intravenous Solution Market is projected to grow at a 7.69% CAGR between 2014-2022.

What will be the value of the Intravenous Solution Market during the forecast period?

Intravenous Solution Market is predicted to touch USD 11,511.2 million by 2022.

Who are the top players profiled in the Intravenous Solution Market?

Top players profiled in the Intravenous Solution Market include Amanta Healthcare (India), Terumo Corporation (Japan), Grifols, SA (Spain), ICU Medical, Inc. (US), B. Braun Melsungen AG (Germany), Fresenius Kabi AG (Germany), and Baxter (US).

What are the key strategies incorporated by industry players to maintain its dominance in the Intravenous Solution Market?

Key strategies incorporated by industry players to maintain its dominance in the Intravenous Solution Market include expansion, product development, innovation, and acquisition.

What are the key factors driving the Intravenous Solution Market growth?

Increasing healthcare expenditure, developing healthcare infrastructure, and rising prevalence of chronic diseases are driving market growth.

GLOBAL INTRAVENOUS (IV) SOLUTIONS MARKET, BY NUTRITIONAL CONTENT, 2022-2030 (USD
GLOBAL INTRAVENOUS (IV) SOLUTIONS MARKET FOR AMINO ACID SOLUTION, BY REGION,
GLOBAL: INTRAVENOUS (IV) SOLUTIONS MARKET, BY REGION, 2022-2030 (USD MILLION)
NORTH AMERICA: INTRAVENOUS (IV) SOLUTIONS MARKET, BY BAG TYPE, 2022-2030 (USD
NORTH AMERICA: INTRAVENOUS (IV) SOLUTIONS MARKET, BY NUTRITIONAL CONTENT, 2022-2030
NORTH AMERICA: INTRAVENOUS (IV) SOLUTIONS MARKET, BY END USER, 2022-2030 (USD
US: INTRAVENOUS (IV) SOLUTIONS MARKET, BY NUTRITION TYPE, 2022-2030 (USD MILLION)
ITALY: INTRAVENOUS (IV) SOLUTIONS MARKET, BY NUTRITIONAL CONTENT, 2022-2030 (USD
ITALY: INTRAVENOUS (IV) SOLUTIONS MARKET, BY END USER, 2022-2030 (USD MILLION)
JAPAN: INTRAVENOUS (IV) SOLUTIONS MARKET, BY NUTRITIONAL CONTENT, 2022-2030 (USD
JAPAN: INTRAVENOUS (IV) SOLUTIONS MARKET, BY END USER, 2022-2030 (USD MILLION)
PHILIPPINES: INTRAVENOUS (IV) SOLUTIONS MARKET, BY BAG TYPE, 2022-2030 (USD MILLION)
PHILIPPINES: INTRAVENOUS (IV) SOLUTIONS MARKET, BY END USER, 2022-2030 (USD MILLION)
THAILAND: INTRAVENOUS (IV) SOLUTIONS MARKET'

Market Segmentation Tab

Intravenous Solution Nutrition Type Outlook (USD Million, 2018-2030)

Total Parenteral Nutrition
Peripheral Parenteral Nutrition

Intravenous Solution Bag Type Outlook (USD Million, 2018-2030)

Large Volume Bags (>250 ml)
Small Volume Bags (<250 ml)

Intravenous Solution Nutritional Content Outlook (USD Million, 2018-2030)

Amino Acid Solution
Carbohydrates
Vitamins & Minerals
Parenteral Lipid Emulsion

Intravenous Solution End User Outlook (USD Million, 2018-2030)

Hospital & Clinics
Ambulatory Surgical Centers
Home Care

Intravenous Solution Regional Outlook (USD Million, 2018-2030)

North America Outlook (USD Million, 2018-2030)
- North America Intravenous Solution by Nutrition Type
  - Total Parenteral Nutrition
  - Peripheral Parenteral Nutrition
- North America Intravenous Solution by Bag Type
  - Large Volume Bags (>250 ml)
  - Small Volume Bags (<250 ml)
- North America Intravenous Solution by Nutritional Content
  - Amino Acid Solution
  - Carbohydrates
  - Vitamins & Minerals
  - Parenteral Lipid Emulsion
- North America Intravenous Solution by End User
  - Hospital & Clinics
  - Ambulatory Surgical Centers
  - Home Care
- US Outlook (USD Million, 2018-2030)
- US Intravenous Solution by Nutrition Type
  - Total Parenteral Nutrition
  - Peripheral Parenteral Nutrition
- US Intravenous Solution by Bag Type
  - Large Volume Bags (>250 ml)
  - Small Volume Bags (<250 ml)
- US Intravenous Solution by Nutritional Content
  - Amino Acid Solution
  - Carbohydrates
  - Vitamins & Minerals
  - Parenteral Lipid Emulsion
- US Intravenous Solution by End User
  - Hospital & Clinics
  - Ambulatory Surgical Centers
  - Home Care
- CANADA Outlook (USD Million, 2018-2030)
- CANADA Intravenous Solution by Nutrition Type
  - Total Parenteral Nutrition
  - Peripheral Parenteral Nutrition
- CANADA Intravenous Solution by Bag Type
  - Large Volume Bags (>250 ml)
  - Small Volume Bags (<250 ml)
- CANADA Intravenous Solution by Nutritional Content
  - Amino Acid Solution
  - Carbohydrates
  - Vitamins & Minerals
  - Parenteral Lipid Emulsion
- CANADA Intravenous Solution by End User
  - Hospital & Clinics
  - Ambulatory Surgical Centers
  - Home Care
- Europe Outlook (USD Million, 2018-2030)
  - Europe Intravenous Solution by Nutrition Type
    - Total Parenteral Nutrition
    - Peripheral Parenteral Nutrition
  - Europe Intravenous Solution by Bag Type
    - Large Volume Bags (>250 ml)
    - Small Volume Bags (<250 ml)
  - Europe Intravenous Solution by Nutritional Content
    - Amino Acid Solution
    - Carbohydrates
    - Vitamins & Minerals
    - Parenteral Lipid Emulsion
  - Europe Intravenous Solution by End User
    - Hospital & Clinics
    - Ambulatory Surgical Centers
    - Home Care
  - Germany Outlook (USD Million, 2018-2030)
  - Germany Intravenous Solution by Nutrition Type
    - Total Parenteral Nutrition
    - Peripheral Parenteral Nutrition
  - Germany Intravenous Solution by Bag Type
    - Large Volume Bags (>250 ml)
    - Small Volume Bags (<250 ml)
  - Germany Intravenous Solution by Nutritional Content
    - Amino Acid Solution
    - Carbohydrates
    - Vitamins & Minerals
    - Parenteral Lipid Emulsion
  - Germany Intravenous Solution by End User
    - Hospital & Clinics
    - Ambulatory Surgical Centers
    - Home Care
  - France Outlook (USD Million, 2018-2030)
  - France Intravenous Solution by Nutrition Type
    - Total Parenteral Nutrition
    - Peripheral Parenteral Nutrition
  - France Intravenous Solution by Bag Type
    - Large Volume Bags (>250 ml)
    - Small Volume Bags (<250 ml)
  - France Intravenous Solution by Nutritional Content
    - Amino Acid Solution
    - Carbohydrates
    - Vitamins & Minerals
    - Parenteral Lipid Emulsion
  - France Intravenous Solution by End User
    - Hospital & Clinics
    - Ambulatory Surgical Centers
    - Home Care
  - UK Outlook (USD Million, 2018-2030)
  - UK Intravenous Solution by Nutrition Type
    - Total Parenteral Nutrition
    - Peripheral Parenteral Nutrition
  - UK Intravenous Solution by Bag Type
    - Large Volume Bags (>250 ml)
    - Small Volume Bags (<250 ml)
  - UK Intravenous Solution by Nutritional Content
    - Amino Acid Solution
    - Carbohydrates
    - Vitamins & Minerals
    - Parenteral Lipid Emulsion
  - UK Intravenous Solution by End User
    - Hospital & Clinics
    - Ambulatory Surgical Centers
    - Home Care
  - ITALY Outlook (USD Million, 2018-2030)
  - ITALY Intravenous Solution by Nutrition Type
    - Total Parenteral Nutrition
    - Peripheral Parenteral Nutrition
  - ITALY Intravenous Solution by Bag Type
    - Large Volume Bags (>250 ml)
    - Small Volume Bags (<250 ml)
  - ITALY Intravenous Solution by Nutritional Content
    - Amino Acid Solution
    - Carbohydrates
    - Vitamins & Minerals
    - Parenteral Lipid Emulsion
  - ITALY Intravenous Solution by End User
    - Hospital & Clinics
    - Ambulatory Surgical Centers
    - Home Care
  - SPAIN Outlook (USD Million, 2018-2030)
  - Spain Intravenous Solution by Nutrition Type
    - Total Parenteral Nutrition
    - Peripheral Parenteral Nutrition
  - Spain Intravenous Solution by Bag Type
    - Large Volume Bags (>250 ml)
    - Small Volume Bags (<250 ml)
  - Spain Intravenous Solution by Nutritional Content
    - Amino Acid Solution
    - Carbohydrates
    - Vitamins & Minerals
    - Parenteral Lipid Emulsion
  - Spain Intravenous Solution by End User
    - Hospital & Clinics
    - Ambulatory Surgical Centers
    - Home Care
  - Rest Of Europe Outlook (USD Million, 2018-2030)
  - Rest Of Europe Intravenous Solution by Nutrition Type
    - Total Parenteral Nutrition
    - Peripheral Parenteral Nutrition
  - REST OF EUROPE Intravenous Solution by Bag Type
    - Large Volume Bags (>250 ml)
    - Small Volume Bags (<250 ml)
  - REST OF EUROPE Intravenous Solution by Nutritional Content
    - Amino Acid Solution
    - Carbohydrates
    - Vitamins & Minerals
    - Parenteral Lipid Emulsion
  - REST OF EUROPE Intravenous Solution by End User
    - Hospital & Clinics
    - Ambulatory Surgical Centers
    - Home Care
  - Asia-Pacific Outlook (USD Million, 2018-2030)
    - Asia-Pacific Intravenous Solution by Nutrition Type
      - Total Parenteral Nutrition
      - Peripheral Parenteral Nutrition
    - Asia-Pacific Intravenous Solution by Bag Type
      - Large Volume Bags (>250 ml)
      - Small Volume Bags (<250 ml)
    - Asia-Pacific Intravenous Solution by Nutritional Content
      - Amino Acid Solution
      - Carbohydrates
      - Vitamins & Minerals
      - Parenteral Lipid Emulsion
    - Asia-Pacific Intravenous Solution by End User
      - Hospital & Clinics
      - Ambulatory Surgical Centers
      - Home Care
    - China Outlook (USD Million, 2018-2030)
    - China Intravenous Solution by Nutrition Type
      - Total Parenteral Nutrition
      - Peripheral Parenteral Nutrition
    - China Intravenous Solution by Bag Type
      - Large Volume Bags (>250 ml)
      - Small Volume Bags (<250 ml)
    - China Intravenous Solution by Nutritional Content
      - Amino Acid Solution
      - Carbohydrates
      - Vitamins & Minerals
      - Parenteral Lipid Emulsion
    - China Intravenous Solution by End User
      - Hospital & Clinics
      - Ambulatory Surgical Centers
      - Home Care
    - Japan Outlook (USD Million, 2018-2030)
    - Japan Intravenous Solution by Nutrition Type
      - Total Parenteral Nutrition
      - Peripheral Parenteral Nutrition
    - Japan Intravenous Solution by Bag Type
      - Large Volume Bags (>250 ml)
      - Small Volume Bags (<250 ml)
    - Japan Intravenous Solution by Nutritional Content
      - Amino Acid Solution
      - Carbohydrates
      - Vitamins & Minerals
      - Parenteral Lipid Emulsion
    - Japan Intravenous Solution by End User
      - Hospital & Clinics
      - Ambulatory Surgical Centers
      - Home Care
    - India Outlook (USD Million, 2018-2030)
    - India Intravenous Solution by Nutrition Type
      - Total Parenteral Nutrition
      - Peripheral Parenteral Nutrition
    - India Intravenous Solution by Bag Type
      - Large Volume Bags (>250 ml)
      - Small Volume Bags (<250 ml)
    - India Intravenous Solution by Nutritional Content
      - Amino Acid Solution
      - Carbohydrates
      - Vitamins & Minerals
      - Parenteral Lipid Emulsion
    - India Intravenous Solution by End User
      - Hospital & Clinics
      - Ambulatory Surgical Centers
      - Home Care
    - Australia Outlook (USD Million, 2018-2030)
    - Australia Intravenous Solution by Nutrition Type
      - Total Parenteral Nutrition
      - Peripheral Parenteral Nutrition
    - Australia Intravenous Solution by Bag Type
      - Large Volume Bags (>250 ml)
      - Small Volume Bags (<250 ml)
    - Australia Intravenous Solution by Nutritional Content
      - Amino Acid Solution
      - Carbohydrates
      - Vitamins & Minerals
      - Parenteral Lipid Emulsion
    - Australia Intravenous Solution by End User
      - Hospital & Clinics
      - Ambulatory Surgical Centers
      - Home Care
    - Rest of Asia-Pacific Outlook (USD Million, 2018-2030)
    - Rest of Asia-Pacific Intravenous Solution by Nutrition Type
      - Total Parenteral Nutrition
      - Peripheral Parenteral Nutrition
    - Rest of Asia-Pacific Intravenous Solution by Bag Type
      - Large Volume Bags (>250 ml)
      - Small Volume Bags (<250 ml)
    - Rest of Asia-Pacific Intravenous Solution by Nutritional Content
      - Amino Acid Solution
      - Carbohydrates
      - Vitamins & Minerals
      - Parenteral Lipid Emulsion
    - Rest of Asia-Pacific Intravenous Solution by End User
      - Hospital & Clinics
      - Ambulatory Surgical Centers
      - Home Care
    - Rest of the World Outlook (USD Million, 2018-2030)
      - Rest of the World Intravenous Solution by Nutrition Type
        Total Parenteral Nutrition
        Peripheral Parenteral Nutrition
      - Rest of the World Intravenous Solution by Bag Type
        Large Volume Bags (>250 ml)
        Small Volume Bags (<250 ml)
      - Rest of the World Intravenous Solution by Nutritional Content
        Amino Acid Solution
        Carbohydrates
        Vitamins & Minerals
        Parenteral Lipid Emulsion
      - Rest of the World Intravenous Solution by End User
        Hospital & Clinics
        Ambulatory Surgical Centers
        Home Care
      - Middle East Outlook (USD Million, 2018-2030)
      - Middle East Intravenous Solution by Nutrition Type
        Total Parenteral Nutrition
        Peripheral Parenteral Nutrition
      - Middle East Intravenous Solution by Bag Type
        Large Volume Bags (>250 ml)
        Small Volume Bags (<250 ml)
      - Middle East Intravenous Solution by Nutritional Content
        Amino Acid Solution
        Carbohydrates
        Vitamins & Minerals
        Parenteral Lipid Emulsion
      - Middle East Intravenous Solution by End User
        Hospital & Clinics
        Ambulatory Surgical Centers
        Home Care
      - Africa Outlook (USD Million, 2018-2030)
      - Africa Intravenous Solution by Nutrition Type
        Total Parenteral Nutrition
        Peripheral Parenteral Nutrition
      - Africa Intravenous Solution by Bag Type
        Large Volume Bags (>250 ml)
        Small Volume Bags (<250 ml)
      - Africa Intravenous Solution by Nutritional Content
        Amino Acid Solution
        Carbohydrates
        Vitamins & Minerals
        Parenteral Lipid Emulsion
      - Africa Intravenous Solution by End User
        Hospital & Clinics
        Ambulatory Surgical Centers
        Home Care
      - Latin America Outlook (USD Million, 2018-2030)
      - Latin America Intravenous Solution by Nutrition Type
        Total Parenteral Nutrition
        Peripheral Parenteral Nutrition
      - Latin America Intravenous Solution by Bag Type
        Large Volume Bags (>250 ml)
        Small Volume Bags (<250 ml)
      - Latin America Intravenous Solution by Nutritional Content
        Amino Acid Solution
        Carbohydrates
        Vitamins & Minerals
        Parenteral Lipid Emulsion
      - Latin America Intravenous Solution by End User
        Hospital & Clinics
        Ambulatory Surgical Centers
        Home Care

Certified Researchers

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Customer Strories

Watch Video

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Jongwon Byun

Director, Research Operations

Case Study

Purchase Options

Intravenous Solution Market

Purchase Options

Market Summary

Market Size & Forecast

Major Players

Market Trends

Global Intravenous Solution Market Overview

Intravenous Solution Market Trends

Market Segment Insights

Smartphone Sensors Smartphone Type Insights

Smartphone Sensors Manufacturer Insights

Smartphone Sensors Application Insights

Smartphone Sensors Regional Insights

Smartphone Sensors Price Insights

Get more detailed insights about Intravenous Solution Market

Key Players and Competitive Insights

Key Companies in the Smartphone Sensors market include

Industry Developments

Market Segmentation

Smartphone Type Outlook

Price Outlook

Manufacturer Outlook

Application Outlook

Manufacturer Outlook

Report Scope

Market Highlights

Author

Leave a Comment

Latest Comments

FAQs

Market Segmentation Tab

Intravenous Solution Nutrition Type Outlook (USD Million, 2018-2030)

Intravenous Solution Bag Type Outlook (USD Million, 2018-2030)

Intravenous Solution Nutritional Content Outlook (USD Million, 2018-2030)

Intravenous Solution End User Outlook (USD Million, 2018-2030)

Intravenous Solution Regional Outlook (USD Million, 2018-2030)

Free Sample Request

Related Reports

Customer Strories

Watch Video

Jongwon Byun

Director, Research Operations

Smartphone Motherboard Parts Manufacturing Research